Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
about
Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidateBiological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalisMouse models for human otitis mediaIdentification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutantEnhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serumIsolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitopeSynthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.Moraxella catarrhalis: from emerging to established pathogen.Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art reviewCharacterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae.Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Role of c-Jun N-terminal protein kinase 1/2 (JNK1/2) in macrophage-mediated MMP-9 production in response to Moraxella catarrhalis lipooligosaccharide (LOS)The AS87_04050 gene is involved in bacterial lipopolysaccharide biosynthesis and pathogenicity of Riemerella anatipestiferMutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.Histophilus somni Stimulates Expression of Antiviral Proteins and Inhibits BRSV Replication in Bovine Respiratory Epithelial Cells.Vaccine targets against Moraxella catarrhalis.Mouse models as a tool to unravel the genetic basis for human otitis media.Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.Identification of two late acyltransferase genes responsible for lipid A biosynthesis in Moraxella catarrhalis.Late acyltransferase genes lpxX and lpxL jointly contribute to the biological activities of Moraxella catarrhalis.The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q24536085-3207AC68-E151-490D-90B8-53ADD3D24797Q24684942-4EBA42F4-8E50-4814-ACBE-F772FC99F850Q27491017-837BAE4F-E87A-4D23-8B73-73BB37B1F00EQ31015760-47DF6535-23D5-40CB-AB61-C6260C1C0880Q33597864-11C46D68-2AB6-4A40-B46F-2A6A254A6503Q33599918-5F8AAB7A-DE09-4684-87C6-78BB32626948Q33762570-1D2EE57F-6FB4-466C-8069-B3DDDF52D68AQ33768943-96703B7E-2B6B-49A1-A8EF-60CB8CB90519Q33883531-F72B5CD5-7F90-4828-8F1E-5281B610CCFDQ33906182-91BA701F-A115-4C52-BCD5-92D2C9E30CFEQ33975684-39295875-4FEB-4386-9599-91B81551C9EFQ33992458-DD8BD4D2-1F4F-4290-AB4B-3D85712463C5Q34002253-7AC8FE2D-510F-4845-A123-DD19393DCC0FQ34006231-378B3F35-3782-42E0-A4A2-A214F65841BBQ34117703-8B0B4704-E4BC-487F-A119-CD332CC84F7BQ34183386-BC6DA086-FD52-4B9A-B9B1-D9A734C26D8BQ34289132-3D4A96A3-01A2-44E5-B98A-387968D7B406Q34323518-878D1F2F-9FF3-4A07-91D8-D3FAC1D5D5FDQ35029651-C68B664A-D91A-46AC-BCD2-AEAEFA0164ABQ35918330-27AB0EFA-FDFD-4A58-BB4F-900EDBAAD2D5Q36483998-A3790FD1-37EB-4E0C-B62E-74B39D1B3446Q36569492-248C0283-FA80-4586-8C41-28435DCA749AQ36845123-E24B5113-6B7B-4E25-A01B-A3133439DAE5Q36979798-D9A8061E-3729-4E6F-B042-27353E720802Q37006478-DD68AC21-FEAB-410D-B861-54E119FDAC73Q39499324-D3E1AA8E-72B7-4550-A7FD-B22A6EBE9BF3Q40074756-043B90F8-FC61-4A4E-9D20-7D15C535183AQ42583054-BDA37347-EF28-40C9-BB30-E1FBD258A2DBQ53701548-5CF30E4A-C11D-471F-ACD7-E33A97812BFB
P2860
Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@ast
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@en
type
label
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@ast
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@en
prefLabel
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@ast
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@en
P2093
P2860
P1476
Synthesis and characterization ...... lla (Branhamella) catarrhalis.
@en
P2093
J B Robbins
S J Barenkamp
P2860
P304
P407
P577
1998-05-01T00:00:00Z